Novo Targets Tresiba for U.S. Approval in First Half of 2013

Novo Targets Tresiba for U.S. Approval in First Half of 2013

Anders Boggild/Novo Nordisk via Bloomberg

An employee holds oral insulin pills, produced by Novo Nordisk A/S, at the company's research and development unit in Malov.